Zdrowie i gospodarka · 30/10/2007

FDA Releases Draft Guidance for Industry on Developing Drugs for Acute Bacterial Sinusitis Treatment

The Food and Drug Administration (FDA) has made available a draft guidance for industry on developing antimicrobial drug products for treating acute bacterial sinusitis (ABS), in line with the agency's evolving thinking and a statutory requirement enacted in 2007.